In gastric cancer cells, quercetin showed antimetastatic effects via breakdown of urokinase plasminogen activator (uPA)/uPA receptor (uPAR) function, by modulating NF-κB, PKC-δ, ERK1/2, and AMPK [96]. Here, PLAU is linked to gastric cancer.